Veratoxin as a New Approach to the Prevention of HIV Infections

The intern will use screening methods to define which gene which are altered in the Jurkat human T cell line following incubation with the Verotoxin B subunit as a means to define the potential mechanism by which this treatment protects these cells from HIV1 infection in vitro. LISI Therapeutics will benefit by increasing their license portfolio to include the rights of Verotoxin B subunit as a potential clinical treatment for HIV/AIDS.

Pei Lin Shi
Faculty Supervisor: 
Dr. Clifford A. Lingwood